Abstract
Metabolic acidosis is one of the common manifestations of Isoniazid toxicity but rare with normally used doses of the drug. Among anti tubercular drugs, rifampicin, streptomycin and capreomycin are commonly implicated in renal injury. Here we report the first case of metabolic acidosis and renal injury caused by isoniazid at normal prescribed dose.
Keywords: Isoniazid, metabolic acidosis, renal dysfunction.
Graphical Abstract
Current Drug Safety
Title:Isoniazid Induced Metabolic Acidosis and Renal Dysfunction in an Elderly Patient with Chronic Renal Disease
Volume: 11 Issue: 2
Author(s): Upinder Kaur, Sankha S. Chakrabarti and Indrajeet S. Gambhir
Affiliation:
Keywords: Isoniazid, metabolic acidosis, renal dysfunction.
Abstract: Metabolic acidosis is one of the common manifestations of Isoniazid toxicity but rare with normally used doses of the drug. Among anti tubercular drugs, rifampicin, streptomycin and capreomycin are commonly implicated in renal injury. Here we report the first case of metabolic acidosis and renal injury caused by isoniazid at normal prescribed dose.
Export Options
About this article
Cite this article as:
Kaur Upinder, S. Chakrabarti Sankha and S. Gambhir Indrajeet, Isoniazid Induced Metabolic Acidosis and Renal Dysfunction in an Elderly Patient with Chronic Renal Disease, Current Drug Safety 2016; 11 (2) . https://dx.doi.org/10.2174/1574886310666151014114509
DOI https://dx.doi.org/10.2174/1574886310666151014114509 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Low Molecular Weight Compounds with Transition Metals as Free Radical Scavengers and Novel Therapeutic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Cyclooxygenase-2 and Prostaglandin E2 are Associated with Middle Cerebral Artery Occlusion and Hemorrhage in Patients with Moyamoya Disease
Current Neurovascular Research The Effect of Antihypertensive Drugs on Carotid Intima Media Thickness: An Up-to-Date Review
Current Medicinal Chemistry Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis
Current Vascular Pharmacology Anti-Inflammatory Gene Therapy for Cardiovascular Disease
Current Gene Therapy Seasonal Allergic Rhinitis
Recent Patents on Inflammation & Allergy Drug Discovery Torasemide for the Treatment of Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume I)
CNS & Neurological Disorders - Drug Targets Adiposity and the Gut - The Role of Gut Hormones
Current Nutrition & Food Science Carbon Monoxide: Medicinal Chemistry and Biological Effects
Current Medicinal Chemistry Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends
Current Vascular Pharmacology Seeking the Active Site of the AT1 Receptor for Computational Docking Studies
Drug Design Reviews - Online (Discontinued) Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia
CNS & Neurological Disorders - Drug Targets Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets An Overview of Emerging Immunotargets of Genitourinary Tumors
Current Drug Targets Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases
Current Drug Targets The Effect of Acute Hypoxia on Excitability in the Heart and the L-Type Calcium Channel as a Therapeutic Target
Current Drug Discovery Technologies New Lipid Modulating Drugs: The Role of Microsomal Transport Protein Inhibitors
Current Pharmaceutical Design Hypotensive Natural Products: Current Status
Mini-Reviews in Medicinal Chemistry Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese
Endocrine, Metabolic & Immune Disorders - Drug Targets